This educational activity is adapted from a live satellite symposium held during the 29th Annual North American Cystic Fibrosis Conference in Phoenix, Arizona (online access: http://www.elseviercme.com/cysticfibrosis/598e). This educational symposium will update clinicians on the changes in disease progression that are now seen in CFTR modulator-treated patients. With the recent scientific advancements and the principles of precision medicine, disease progression and quality of life are drastically improving for patients with cystic fibrosis. Current clinical trial data shows new and emerging therapeutic options that are beneficial to specific gene mutations. Expert faculty will present comprehensive case studies and conduct interactive panel discussions to enhance your knowledge in the advanced science of cystic fibrosis and patient management strategies.
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Pulmonary and Respiratory Medicine